Peritonitis: Main reason of severe sepsis in surgical intensive care;Die Peritonitis - Hauptursache Schwerer Sepsis auf Chirurgischer Intensivstation

Zentralblatt fur Chirurgie

Volumn 132, Issue 2, 2007, Pages 130-137

  Weiss, G ^a,b   Steffanie, W ^a   Lippert, H ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b Stadtisches Klinikum Magdeburg   (Germany)

Author keywords

Epidemiology; Hospital aquired infections; Peritonitis; Sepsis

Indexed keywords

ADOLESCENT; ADULT; AGED; CROSS INFECTION; CROSS-SECTIONAL STUDY; FEMALE; GERMANY; HEALTH SURVEY; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; MALE; MIDDLE AGED; MORTALITY; PERITONITIS; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; SEPSIS; SEPTIC SHOCK; STATISTICS; SURGICAL INFECTION; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS INFECTION; CROSS-SECTIONAL STUDIES; FEMALE; GERMANY; HEALTH SURVEYS; HOSPITAL MORTALITY; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PERITONITIS; PROGNOSIS; RETROSPECTIVE STUDIES; SEPSIS; SHOCK, SEPTIC; SURGICAL WOUND INFECTION;

EID: 34250169444     PISSN: 0044409X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-960478     Document Type: Review

References (49)

1. Alberti C, Brun-Buisson C, Burchardi H, Martin C et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 2002; 28: 108-121
2. Angus DC, Wax RS. Epidemiology of sepsis: an update. Crit Care Med 2001; 29: 1109-1116
3. Angus DC, Linde-Zwirble W, Lidicker J, Clermont G, Carcillo J, Pinsky R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2000; 29: 1303-1310
4. Berger D, Butteenschoen K. Management of abdominal sepsis. Langenbecks Arch Surg 1998; 383: 35-43
5. Bloos F, Reinhart K. New treatment approaches in sepsis. Zentralbl Chir 2002; 127: 174-179
6. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbad WJ. Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101: 1644-1655
7. Brun-Buisson C, Doyon F, Carlet J, Dellamonica P et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. JAMA 1995; 27: 968-974
8. Brun-Buisson C. The epidemiology of the systemic inflammatory response. Intensive Care Med 2000; 26: 64-74
9. Bruch HP, Weltmann A, Eckmann C. Surgical management of peritonitis and sepsis. Zentralbl Chir 1999; 124: 176-180
10. Brügger LE, Seiler CA, Mittler M, Balsinger B, Feodorovici M, Büchler MW. New surgical treatment approaches of diffuse peritonitis. Zentralbl Chir 1999; 124: 181-186
11. Brunkhorst FM, Karzai W, Reinhart K. Diagnostic approach to sepsis-state of the art. Zentralbl Chir 2002; 127: 165-173
12. Büchler MW, Baer HU, Brügger LE, Feodorovici MA, Uhl W, Seiler CH. Surgical treatment of diffuse peritonitis: treatment of focus and intraoperative extensive lavage. Chirurg 1997; 68: 811-815
13. Buijk SE, Bruining HA. Future directions in the management of tertiary peritonitis. Intensive Care Med 2002; 28: 1024-1029
14. Calandra T, Cohen J. The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med 2005; 33: 1538-1548
15. Engelmann L. Patients with sepsis die of "second hit". Intensiv-News 2003; 5/03: 1-2
16. Evans H, Raymond DP, Pelletier S, Crabtree T, Preutt T, Sawyer R. Diagnosis of intraabdominal infection in the critically ill patients. Current opinion in Critical Care 2001; 7: 117-121
17. Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, Jimenez F, Perez-Paredes C, Ortiz-Leyba C. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 2003; 31: 2742-2752
18. Gießling U, Petersen S, Freitag M, Kleine-Kraneburg H, Ludwig K. Surgical management of severe peritonitis. Zentralbl Chir 2002; 127: 594-597
19. Hanisch E, Encke A. Intensive care management in abdominal surgical patients with septic complications. In: Faist E (ed). Immunological Screening and Immunotherapy in Critically ill Patients with Abdominal Infections. Springer, Berlin, Heidelberg, New York 2001; 71-83
20. Harbarth S, Fernere K, Hugonnet S, Ricou B, Suter P, Pittet D. Epidemiology and prognostic determinants of bloodstream infections in surgical intensive care. Arch Surg 2002; 137: 1353-1359
21. Hoste E, Blot S, Lameire N, Vanholder R, De Bacquer D, Colardyn F. Effect of nosocomial bloodstream infection on the outcome of critically ill patients with acute renal failure treated with renal replacement therapy. J Am Soc Nephrol 2004; 15: 454-462
22. Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH. Clinical importance of delays in the initiation of appropriate treatment for ventilator associated pneumonia. Chest 2002; 122: 262-268
23. Kollef MH, Sherman G, Ward S, Fraser V. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999; 115; 462-474
24. Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000; 31: 131-138
25. Lamme B, Boermeester MA, Reitsma JB, Mahler CW, Obertop H, Gouma DJ. Metaanalysis of relaparotomy for secondary peritonitis. Br J Surg 2002; 89: 1516-1524
26. Lefering R. First results from the national register for external quality control in the ICU. Intensivmed 2002; 39: 334-340
27. Leone M, Bourgoin A, Cambon S, Dubue M, Albanese J, Claude M. Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome. Crit Care Med 2003; 31: 462-467
28. Leroy O, Meybeck A, Escrivan T, Devos P, Kipnis E, Georges H. Impact of adequacy of initial antimicrobial therapy on the prognosis of patients with ventilator associated pneumonia. Intensive Care Med 2003; 29: 2170-2173
29. Luna CM, Vujacich P, Niederman MS, Vay C, Gherardi C, Matera J, Jolly EC. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997; 111; 676-685
30. MacArthur R, Miller M, Albertson T, Panacek E, Johnson D, Teoh L, Barchuk W. Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the monarcs trial. Clin Infect Dis 2004; 38: 284-288
31. Moerer O, Schmid A, Hofmann M, Herklotz A, Reinhard K, Werdan K, Schneider H, Burchardi H. Direct costs of severe sepsis in three german intensive care units based on retrospective electronic patient record analysis of resource use. Intensive Care Med 2002; 28: 1440-1446
32. Müller-Werdan U. The woman as intensive care patient: sepsis, artificial respiration, sedation. Intensivmed 2004; 41: 203-206
33. Nathens AB, Rotstein O, Marshall JC Tertiary peritonitis: clinical features of a complex nosocomial infection. World J Surg 1998; 22: 158-163
34. National centrum of surveillance of hospital aquired infections. Consumption of antibiotics on the ICU of SARI in 2000-2004.www.nrz-hygiene.de
35. Pittet D, Hansjakob F. Reduction of personal and hospital aquired infections. Swiss-NOSE 1997; 4: 1-5
36. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T et al. The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA 1995; 273: 234-240
37. Reith HB, Mittelkötter U. Markers of inflammation for prognosis and control of therapeutic success in patients with abdominal sepsis - options for using adjuvant intravenous immunoglobulins. In: Faist E (ed). Immunological Screening and Immunotherapy in Critically ill Patients with Abdominal Infections. Springer, Berlin, Heidelberg, New York 2001; 15-28
38. Rello J, Ausina V, Ricart M, Castella J, Prats G. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest 1993; 104: 1230-1235
39. Schein M. Surgical management of intraabdominal infection: is there any evidence? Langenbecks Arch Surg 2002; 387: 1-7
40. Schramm H, Fiedler I. Chirurgische Therapie der Peritonitis. In: Fleischer CM (Hrsg). Actual Surgery of Infections, Johann Ambrosius Barth, Heidelberg, Leipzig 1999; 143-148
41. Schröder J, Kahlke V, Staubach K-H, Zabel P, Stüber P. Gender differences in human sepsis, Arch Surg 1998; 133: 1200-1205
42. Schröder J, Kahlke V, Book M, Stüber F. Gender differences in sepsis: genetically determined? Shock 2000; 14: 307-311
43. Sutherland AM, Walley KR, Russell JA. Polymorphisms in CD 14, mannose-binding lectin, and toll-like receptor-2 are associated with increased prevalence of infection in critically ill adults. Crit Care Med 2005; 33: 638-644
44. Sundararajan V, MacIsaac CM, Presneill JJ, Cade JF, Visvanathan K. Epidemiology of sepsis in Viktoria, Australia. Crit Care Med 2005; 33: 71-80
45. Wacha H, Hau T, Dittmer R, Ohmann C. Risk factors associated with intraabdominal infections: a prospective multicenter study, Langenbecks Arch Surg 1999; 384: 24-32
46. Wichmann MW, Müller CH, Meyer G, Adam M, Angele MK, Eisenmenger SJ, Schildberg FW. Different immune response to abdominal surgery in men and women. Langenbecks Arch Surg 2003: 387
47. Widmer AF. Infection control and prevention strategies in the ICU. Intensive Care Med 1994; 20: 7-11
48. Winkeltau G, Winkeltau GU, Klosterhalfen B, Niemann H, Treutner KH. Schumpelick Different surgical therapy of diffuse peritonitis. Chirurg 1992; 63: 1035-1040
49. Winkeltau GJ, Treutner KH. Klassifizierung und Schweregrade. In: Winkeltau GJ (Hrsg). Diffuse Peritonitis. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart 1995; 54-62